This Article Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Reiser, S. J. Search for Related Content PubMed PubMed Citation Articles by Reiser, S. J. Related Collections Research And Technology Elderly

Health Affairs, Vol 13, Issue 3, 127-136
Copyright © 1994 by Project HOPE

Journal Article

Criteria for standard versus experimental therapy

This paper demarcates the boundaries between experimental and standard therapy and the influence of this division on policy, payment, and practice. It proposes a new category, crossover therapy, to deal with the many therapies that fall in between. It establishes four criteria to separate these categories: (1) the populations and conditions for which use is helpful; (2) the expected outcomes of care; (3) the skill, personnel, and site requirements and the economic, ethical, and legal understandings essential for use; and (4) the level of knowledge needed to certify that prospective users can apply it well. The paper then explores the use of experimental therapy in desperate situations and of standard therapies in new areas and gives policy recommendations to facilitate these actions.

                      What's this?

This article has been cited by other articles:

				S. R. Tunis and S. D. Pearson Coverage Options For Promising Technologies: Medicare's 'Coverage With Evidence Development' Health Aff., September 1, 2006; 25(5): 1218 - 1230. [Abstract] [Full Text] [PDF]